Filing Details
- Accession Number:
- 0001140361-10-031125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-02 13:00:00
- Reporting Period:
- 2010-07-29
- Filing Date:
- 2010-08-02
- Accepted Time:
- 2010-08-02 18:03:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885988 | Integramed America Inc | INMD | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 061150326 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1311443 | Blueline Partners, L.l.c. | 402 Railroad Avenue Suite 201 Danville CA 94526 | No | No | Yes | No | |
| 1338149 | Blueline Capital Partners, L.p. | 402 Railroad Avenue, Ste 201 Danville CA 94526 | No | No | Yes | No | |
| 1411986 | Blueline Capital Partners Iii, Lp | 402 Railroad Avenue Suite 201 Danville CA 94526 | No | No | Yes | No | |
| 1411987 | Blueline Partners Ii, Llc | 402 Railroad Avenue Suite 201 Danville CA 94526 | No | No | Yes | No | |
| 1453017 | Blue Tsv I, Ltd. | C/O Maples Corporate Services Limited Po Box 309, Ugland House Grand Cayman E9 KY1-1104 | No | No | Yes | No | |
| 1460518 | Blueline Catalyst Fund Ix, L.p. | 402 Railroad Avenue Suite 201 Danville CA 94526 | No | No | Yes | No | |
| 1460781 | Blueline Capital Partners Ii, L.p. | 402 Railroad Avenue Suite 201 Danville CA 94526 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-07-29 | 6,000 | $8.05 | 1,181,374 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2010-07-29 | 4,300 | $8.14 | 1,185,674 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2010-08-02 | 52,672 | $8.18 | 1,238,346 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- These securities are owned by BlueLine Catalyst Fund IX LP, who is a member of a "group" with BlueLine Capital Partners LP, BlueLine Capital Partners II LP, BlueLine Capital Partners III LP, BlueLine Partners LLC, the sole general partner of BlueLine Capital Partners LP, BlueLine Capital Partners II LP and BlueLine Catalyst Fund IX LP, BlueLine Partners II LLC, the sole general partner of BlueLine Capital Partners III LP, and Blue TSV I LTD. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. The above Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.
Billionaire Hedge Funds
